ArticleCureus2025
Association of rs7216389 Polymorphism in Gasdermin B (GSDMB) With Childhood Asthma: A Case-Control Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective This study examines the association between the gasdermin B (GSDMB) gene variant rs7216389 and childhood asthma, with a focus on gender-based differences, environmental factors, and lung function measurements in affected children. It highlights the growing prevalence of childhood asthma, its unique features compared to adult-onset asthma, and the substantial healthcare burden it imposes, especially during exacerbations. Methods A case-control study was conducted over 18 months at CMH Lahore, UHS, and Children's Hospital, including 200 participants (100 asthmatics, 100 controls) aged three to 18. Blood samples were analyzed for genetic factors. IBM SPSS Statistics for Windows, Version 25.0 (Released 2017; IBM Corp., Armonk, NY, USA) was used for statistical analysis, with significance at p < 0.05. Ethical approval and informed consent were obtained. Results The study identifies the GSDMB variant rs7216389 as a potential genetic marker for asthma, underscoring its association with the severity of the condition in children. It highlights the challenges of translating genetic findings into clinical practice while emphasizing the therapeutic potential of targeting these genetic markers. The study also sheds light on healthcare costs and the distinctive clinical features of pediatric asthma, further contextualizing its impact. Conclusions This article provides a comprehensive overview of asthma pathogenesis, emphasizing the significance of genetic markers like rs7216389 in the GSDMB gene. It advocates for further research to unravel the complex interplay of genetic, environmental, and immune factors in childhood asthma, intending to develop targeted therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.